0001493152-21-010006.txt : 20210429 0001493152-21-010006.hdr.sgml : 20210429 20210429140652 ACCESSION NUMBER: 0001493152-21-010006 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201221 FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roberts Brad Michael CENTRAL INDEX KEY: 0001844066 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 21869375 MAIL ADDRESS: STREET 1: 300 CHAFFORD COURT CITY: SIMPSONVILLE STATE: SC ZIP: 29681 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 3/A 1 ownership.xml X0206 3/A 2020-12-21 2021-02-03 0 0000948320 LifeMD, Inc. LFMD 0001844066 Roberts Brad Michael C/O LIFEMD, INC., 800 THIRD AVENUE, SUITE 2800 NEW YORK, NY 10022 0 1 0 0 Chief Operating Officer Common Stock 62632 D Options to purchase shares of Common Stock Common Stock, par value $0.001 200000 D This Form 3 amendment is being filed to correct the number of shares directly owned Mr. Roberts as of December 21, 2021. Consisting of: (i) 10,000 restricted stock units of the Company's common stock; (ii) 52,632 shares of common stock of the Issuer, purchased by Mr. Roberts on November 6, 2020, in a private placement offering by the Company. Pursuant to the terms of the amended and restated employment agreement, by and between Mr. Roberts and the Issuer, on January 8, 2021 (the "Effective Date"), Mr. Roberts was granted: (i) 10,000 restricted stock units of the Company's common stock (the "RSUs") which shall vest on December 21, 2021; and (ii) stock options to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.50 per share (the "Stock Options"). 35,000 of the Stock Options vested on the Effective Date, with the remaining Stock Options scheduled to vest in equal monthly tranches, based on the passage of time, over the 30 months following the approval of the Effective Date. /s/ Brad Roberts 2021-04-29